Register for OBR daily




To find out more about a company click on the company name to see a brief profile.

OBR Finance Top 5 Winners

ENZN $1.41 0.2037 +16.83%
ONCY $0.62 0.0800 +14.81%
DVAX $25.47 1.9000 +8.06%
NLNK $45.89 2.6700 +6.18%
AGEN $9.14 0.5290 +6.14%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

OBR Finance Top 5 Losers

OHRP $2.29 -0.1900 -7.66%
GTXI $1.46 -0.1099 -7.00%
BPTH $1.12 -0.0800 -6.67%
PVCT $0.53 -0.0279 -4.98%
CBMG $35.41 -1.7900 -4.81%

Quotes Are Updated Every 20 Minutes. Companies with a Market Cap of less than $50M are not included.

Archived News Headlines

We have been archiving all OBR daily news stories since March 2008. Use the box below to search our archives for specific articles and content.

Please note: we do not "host" news articles on our website. When a media source removes an article from their website the link becomes inactive, and you will only be able to see the date, title, first sentence and media source that published the article.

<< First | < Prev | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | Next > | Last >>

Caladrius Biosciences Announces First Patient Dosed in Phase 3 Immunotherapy Trial for Melanoma

(MarketWatch) June 23, 2015 - Caladrius Biosciences, Inc., a cell therapy leader with a late-stage clinical program for immuno-oncology, announced today the dosing of the first patient in the Intus Phase 3 clinical trial.
read article 



TapImmune Reports Robust Immune Responses Generated in 19 of 20 Evaluable HER2/neu Breast Cancer Patients

(CNNMoney) June 23, 2015 - TapImmune Inc. is pleased to report the completion of data analysis from patients treated in a Phase I clinical trial.
read article 



Researchers Develop New Breath Test To Diagnose Oesophageal And Gastric Cancer

(Imperial College London [UK]) June 23, 2015 - Researchers have devised a breath test that can help doctors diagnose the early signs of oesophageal and gastric cancer in minutes.
read press release 



Many With Early Breast Cancer Have Too Many Imaging Tests

(Reuters Health) June 22, 2015 - Nearly nine in 10 women with early breast cancer have imaging exams to see if the cancer has spread, despite official recommendations against such tests, a new study suggests.
read article 



‘Smarter’ Ordering of Breast Biomarker Tests Could Save Millions in Health Care Dollars, Study Reveals

(Johns Hopkins Medicine) June 23, 2015 - A review of medical records for almost 200 patients with breast cancer suggests that more selective use of biomarker testing for such patients has the potential to save millions of dollars in health care spending without compromising care.
read press release 



New Multiple Myeloma Regimen Is Also Effective in Elderly

(Medscape Medical News) June 22, 2015 - A treatment regimen of lenalidomide and low-dose dexamethasone shows significant improvements in progression-free survival in patients over 75 similar to those under 75.
read article (free registration required) 



The Challenges of Incorporating Gene Panels Into Clinical Practice

(Medscape Oncology) June 22, 2015 - In the past several years, an increasing number of gene panel tests have become available for use in the clinic. At the recent annual meeting of the American Society of Clinical Oncology (ASCO), speakers discussed some of the controversies and clinical dilemmas surrounding these tests.
read article (free registration required) 



NICE’s New Symptom–Based Approach Will Help To Save Thousands Of Lives From Cancer

(NICE) June 23, 2015 - NICE has updated and redesigned its guideline to support GPs to recognise the signs and symptoms of 37 different cancers and refer people for the right tests faster.
read article 



Cancer Drugs Get A New Consumer's Guide

(Los Angeles Times/Science Now) June 22, 2015 - In a bid to inject clarity into the fast-moving, high-stakes world of cancer drugs, a task force of cancer doctors announced Monday that it has devised a decision-making aid to help physicians and their patients weigh the pluses and minuses of newly available options for treating malignancy, including their costs.
read article (free registration required) 



Current Blood Cancer Drug Prices Not Justified, MD Anderson Study Finds

(MD Anderson) June 22, 2015 - In a new analysis, researchers at The University of Texas MD Anderson Cancer Center concluded the majority of existing treatments for hematologic, or blood, cancers are currently priced too high to be considered cost-effective in the United States.
read press release 



NHS Cancer Guide For GPs And Patients Could Save 5,000 Lives A Year, Says Nice

(The Guardian [UK]) June 22, 2015 - Guidance on symptoms and tests drawn up by the National Institute for Health and Care Excellence for doctors and patients could transform cancer care in UK.
read article 



ASCO Publishes Conceptual Framework to Assess the Value of New Cancer Treatment Options

(ASCO) June 22, 2015 - The American Society of Clinical Oncology (ASCO) today published an initial version of a conceptual framework for assessing the value of new cancer treatment options based on clinical benefit, side effects, and cost.
read press release 



Many Physicians Still Unprepared for ICD-10

(Medscape Medical News) June 22, 2015 - Few practices have done external or internal testing; meanwhile, the AAFP asks CMS to suspend ICD-10-related audits by RACs.
read article (free registration required) 



A Sea Change in Treating Heart Attacks

(New York Times) June 19, 2015 - The death rate from coronary heart disease has dropped 38 percent in a decade. One reason is that hospitals rich and poor have streamlined emergency treatment.
read article 



Insurers, Hospitals Brace for Affordable Care Act Ruling

(Wall Street Journal) June 22, 2015 - Hospitals, doctors and consumers prepare for fallout if the Supreme Court strikes down subsidies that help 6.4 million Americans buy insurance.
read article (paid subscription required) 



Cigna Rejects $47 Billion Anthem Bid Amid Leadership Clash

(Bloomberg) June 21, 2015 - Cigna Corp. rejected Anthem Inc.’s $47 billion takeover bid, saying it was inadequate, not in the best interests of shareholders and that Anthem’s management wasn’t fit to lead a merged insurance giant.
read article 



ERYTECH Announces Two Positive DSMB Reviews

(Digital Journal) June 22, 2015 - Dose escalation to next dose level and acceleration of patient enrollment recommended in US Phase I study with ERY-ASP in Acute Lymphoblastic Leukemia (ALL); continuation of enrollment recommended in the ERY-ASP/Folfox treatment arm in Phase II pancreatic cancer study.
read article 



President Obama Announces More Key Administration Posts

(Whitehouse.gov) June 18, 2015 - President Obama announced his intent to appoint the following individuals to key Administration posts on the National Cancer Advisory Board:
read press release 



Hawaii Becomes First U.S. State To Raise Smoking Age To 21

(Reuters) June 20, 2015 - Hawaii's governor on Friday signed a bill raising the legal smoking age statewide to 21, the first U.S. state to do so.
read article 



The Good News, At Last, In Prostate Cancer Screening

(Common Sense MD blog) June 19, 2015 - As I previously documented in a series of posts on this blog, the road to the U.S. Preventive Service Task Force's 2012 "don't do it" recommendation on PSA-based screening for prostate cancer was long, arduous, and full of political pitfalls.
read article 



Abbott OKs Ousting Planned Parenthood From Cancer Program

(The Texas Tribune) June 20, 2015 - A months-long effort to keep Republicans from pushing Planned Parenthood out of a state cancer screening program for low-income women ended in defeat on Saturday when Republican Gov. Greg Abbott signed off on the proposal.
read article 



Transgenomic Announces Plans to Launch Liquid Biopsy Cancer Test Pipeline During 2015

(TheStreet) June 22, 2015 - Plans to release up to six new lab-based cancer tests this year targeting actionable mutations in melanoma, lung cancer and colorectal cancer for use with tissue or liquid biopsy samples.
read article 



IMS Health and Foundation Medicine Announce Collaboration to Optimize Targeting of Precision Therapies in Oncology

(Yahoo! Finance) June 22, 2015 – IMS Health and Foundation Medicine, Inc. today announced a collaboration to advance the understanding and effectiveness of precision medicines for treating cancer.
read article 



Kite, Bluebird Partner For New Cancer Therapies

(Reuters) June 22, 2015 - Cancer drug developers Kite Pharma Inc and Bluebird Bio Inc said they would partner to develop and market a new class of T-cell therapies for HPV-associated cancers.
read article 



Epizyme Announces Additional Positive Data from Ongoing Phase 1 Study of Tazemetostat (EPZ-6438) in Relapsed or Refractory Non-Hodgkin Lymphoma

(TheStreet) June 20, 2015 - Epizyme, Inc. today reported results from the ongoing phase 1 trial of tazemetostat (EPZ-6438), a first-in-class EZH2 inhibitor, showing meaningful clinical activity when used as an oral monotherapy in patients with advanced B-cell non-Hodgkin lymphomas (NHL) and solid tumors.
read article